Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
Information
- Disease name
- Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03213665 | Active, not recruiting | Phase 2 | Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial) | November 13, 2017 | September 22, 2024 |
| NCT04530487 | Recruiting | Phase 2 | Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults | August 19, 2020 | May 9, 2025 |